Medicinal Chemistry graduate students Elbek Kurbanov in Dr. Elizabeth Amin's lab and John Widen from Dr. Dan Harki's lab have been awarded College of Pharmacy Bighley Fellowships for 2013-14.
Institute for Therapeutics Discovery & Development (ITDD) Directors Gunda Georg and Vadim Gurvich were featured in the HealthTalk story, "New $8.3M NIH contract to advance hormone-free birth control research at University of Minnesota."
Institute for Therapeutics Discovery & Development (ITDD) faculty will receive $8.3 million from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to investigate pharmaceutical alternatives to existing birth control methods.
The primary goal of the five-year research contract is to both develop new non-hormonal male and female birth control drug targets and expand on existing targets.
A $23,000 Engebretson/Bighley Drug Design & Development Grant was awarded to faculty member Dan Harki for his project "Discovery of APOBEC3B Small Molecule Inhibitors."
Professor David Ferguson is featured in the October 16 Academic Health Center HealthTalk story "Expert Perspective: Workout enhancer contains meth-like stimulant."
Professor David Ferguson was quoted in the September 19 Minnesota Daily article "Molly drug use more common than U think."
Graduate student Maggie Olson has been selected to receive a Division of Medicinal Chemistry Predoctoral Fellowship for 2013-14 from the American Chemical Society. Maggie is a member of Dan Harki's lab.
Medicinal Chemistry Department Head and Institute for Therapeutics Discovery & Development Director Gunda Georg will receive $8.3 million over five years from the National Institute for Child Health and Human Development to design, synthesize, and evaluate non-hormonal contraceptives for men and women.
A recent publication co-authored by the Turesky lab on genome-wide sequencing of mutations and DNA adducts linking aristolochic acid to cancer is featured as an NIEHS Paper of the Month. "Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing" was published August 7 in Science Translational Medicine.
Professor Robert Turesky was featured in the September 10 Academic Health Center HealthTalk story, "Research Q&A: Identifying cancer's source."